When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
XLRN - Morgan Stanley sees 33% upside in stock that jumped 74% last week
Acceleron Pharma Inc.
Citing "substantial upside potential" in pulmonary arterial hypertension (PAH), Morgan Stanley has upgraded Acceleron Pharma (XLRN+2.4%) to Overweight with a boost in its fair value target to $122 (33% upside) from $52.
More news on: Acceleron Pharma Inc., Healthcare stocks news, Stocks on the move, ,